A national-level workshop on muscular dystrophy and related genetic disorders was held at the Integrated Muscular Dystrophy Rehabilitation Centre (IMDRC), Manav Mandir, in Kothon village.

Deflazacort is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older. Duchenne Muscular Dystrophy (DMD) is a genetic disorder ...

Then came a devastating diagnosis. Then two months ago, the Bridgeman Downs family learned Araliyah, 5, suffers from Emery Dreifuss muscular dystrophy (LNMA AD). The degenerative disease affects ...

With grace that extends far beyond the pageant stage, Miss Asia Pacific World 2013 Srishti Rana recently took to Instagram to champion a cause close to countless hearts—raising awareness for children ...

Aaron was born with muscular dystrophy and suffered a stroke in 2023, then spent much of the following year recovering in the Midwest because of Maui's limited medical resources. "It was beyond ...

Firefighters are in the street holding boots to collect donations. CTV’s Ainsley McPhail learns other ways you can donate to Muscular Dystrophy Canada ...

Upon approval, vamorolone would be the first and only treatment option indicated for patients diagnosed with Duchenne muscular dystrophy in Canada The Canadian regulatory submission of vamorolone ...

Previously, Dr. Gita serves patients at the Ajiwaras Clinic, Cilandak KKO. Here are the causes and treatment for the congenital disorder Duchenne muscular dystrophy! Entering the age of 2 years, ...

for the treatment of myotonic dystrophy type 1 (DM1), an investigational treatment designed to address the root cause of DM1, an underrecognized, progressive and often fatal neuromuscular disease ...

More information: Dariusz C. Górecki et al, Is dystrophin immunogenicity a barrier to advancing gene therapy for Duchenne muscular dystrophy? Gene Therapy (2025). DOI: 10.1038/s41434-025-00531-y ...

Suneel Ram’s needs gradually became greater after he was diagnosed at age 3 with Duchenne muscular dystrophy, a muscle-wasting genetic disorder that afflicts one in 5,000 boys. Today ...

Global Duchenne Muscular Dystrophy Drugs Market value attained USD 3.9 Billion in 2025. The market will achieve USD 6.5 Billion during 2034 with a growth rate (CAGR) of 10.96% during the forecast ...